Skip to content
Sunday 30 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,824.26
+0.29%
DAX
26,569.99
+0.77%
CAC 40
8,401.18
+0.98%
STOXX 50
6,485.67
+0.95%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Wednesday 03 May 2023 10:25 am

As FCA rewrites listing rules, another firm ditches London due to ‘regulatory burden’

By: Charlie Conchie

City Editor

Add as a preferred source on Google
A group of LSEG investors including Blackstone and Thomson Reuters are offloading a four per cent stake in the firm worth £1.9bn, the London Stock Exchange owner has said today
LSEG has said it will buy back around £500m of the shares as part of the deal.

A London-listing and the associated tangle of regulatory red tape inflict more pain on firms than benefits, an AIM-listed renewables firm said today, as it announced plans to ditch its quoted status in the City.

Solgenics, an African renewables development firm listed on London’s smaller AIM market, said today it had decided to delist due to the “regulatory burden” placed on the company and its belief that reporting requirements were allowing privately owned peers to gain a competitive edge.

“The considerable cost, management time and legal and regulatory burden associated with maintaining the company’s admission to trading on AIM are disproportionate to the benefits to the company,” Solgenics said in a statement.

“There are negative operational influences on the business, which come about directly as a result of being quoted, something which is accentuated by operating in an industry where the vast majority of the company’s peers are privately owned,” it added.

Shares in the firm cratered after the announcement, dropping some 70 per cent in early trading.

While Solgenics is at the small end of London’s listed firms with a market capitalisation of £3.26m before market open, the comments underscore the troubles facing the London Stock Exchange as it looks to tempt growing firms to come to market.

The City earned just five new listings in the first quarter of 2023 raising just £81m, while a slew of firms have announced plans to ditch their listings or snubbed London for an IPO, including the Cambridge chipmaker Arm.

Regulators in the UK have just announced sweeping plans to slash red tape and try and boost the appeal of London’s markets.

In an announcement yesterday, the Financial Conduct Authority acknowledged that the UK’s listing regime was seen by some as too complicated and tabled plans to merge the ‘standard’ and ‘premium’ listing segments with a single category.

The watchdog argued the reforms would create “a simpler and more accessible UK listing regime for companies, improving the attractiveness of listing in the UK and providing a wider range of investment opportunities for investors.”

Read more

Watchdog takes aim at lawyers blaming juniors for AI blunders

Thousands of justice staff disciplined over the last three years

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News
  • Markets & Economics

Categories

  • Business
  • Investing
  • Markets

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Jamie Carragher: HMRC petitions for Sky Sports star to be declared bankrupt

  • Jamie Vardy bags Bundesliga rights as he steps up streaming war with Neville and Lineker

  • City firms mandate phone and face-to-face comms bootcamps for Gen Z lawyers

  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

More from Morning Wire

  • Watchdog takes aim at lawyers blaming juniors for AI blunders

    Legal
    Thousands of justice staff disciplined over the last three years
  • Zilch, Clearscore among five UK scale-ups to get dedicated FCA support

    Tech
    PhilandSean ZilchCo founders discussing business strategy in an office setting, highlighting innovative leadership and tea...
  • London AI car firm records surge in revenue on demand for driver-tracking software

    Tech
    Seeing Machines Guardian device mounted on a desk, with a computer monitor in the background.
  • Glencore targets secondary listing in Australia as London loses mining shine

    Mining
    Glencore corporate headquarters building exterior with the company logo sign, representing the commodities firm.
  • IPO tweaks are welcome, but London’s market needs root and branch reform

    Opinion
    Busy London Stock Exchange trading floor in the 1980s with brokers at hexagonal trading posts.
  • Astrazeneca share price tumbles on $400bn megamerger talks

    Investing
    Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure
  • Airtel and Sumup set to kick off London’s fintech IPO test

    Fintech
    Hand holding black SumUp payment card over a white contactless reader on a marble table with breakfast food
  • Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook